BI 416970

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 416970, covering 2016-03-22 to 2016-03-22. Get the full timeline:

Most recent: Clinical Trial Update: To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers [Phase 1]